Rifampin for Injection is a semi synthetic antibiotic indicated for the treatment of both tuberculosis and meningococcal carriers.
Akorn-Strides is a joint venture that was formed in 2005 by Akorn, and Strides Arcolab. The primary mission for the joint venture is to develop liquid, lyophilized and dry powder formulations of generic injectable products targeting several therapeutic markets with a major focus on anti-infectives, analgesics and CNS medicines.